SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-005829
Filing Date
2018-01-29
Accepted
2018-01-29 16:17:35
Documents
1
Period of Report
2018-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 25580
  Complete submission text file 0001209191-18-005829.txt   28236
Mailing Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025
Business Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025 650-486-1416
Menlo Therapeutics, Inc. (Issuer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 650 688 0818
Vivo Capital Fund VIII, L.P. (Reporting) CIK: 0001618788 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38356 | Film No.: 18555701

Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 650 688 0822
Vivo Capital VIII, LLC (Reporting) CIK: 0001618789 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38356 | Film No.: 18555703

Mailing Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301
Business Address 505 HAMILTON AVENUE, SUITE 200 PALO ALTO CA 94301 650 688 0818
Vivo Capital Surplus Fund VIII, L.P. (Reporting) CIK: 0001628048 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38356 | Film No.: 18555702